Advertisement

Function of the Central Catecholaminergic Neuron: Synthesis, Release, and Inactivation of Transmitter

  • Paul Mandel
  • Gérard Mack
  • Christo Goridis

Abstract

The term “catecholamine” refers to a series of organic compounds which have a benzene nucleus with two adjacent hydroxyl groups (the catechol nucleus) and amine group. Thus dopamine (dihydroxyphenylethylamine), noradrenaline (β-hydroxy dihydroxyphenylethylamine), and adrenaline (N-methyl-β-hydroxy dihydroxyphenylethylamine) and certain of their metabolites are catecholamines.

Keywords

Tyrosine Hydroxylase Synaptic Vesicle Monoamine Oxidase Monoamine Oxidase Inhibitor Fusaric Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alousi, A., and Weiner, N., 1966, Proc. Natl. Acad. Sci. (U.S.) 56: 1491.CrossRefGoogle Scholar
  2. Anden, N. E., Corrodi, H., Fuze, K., Hökfelt, T., Rydin, C., and Svensson, T., 1970, Life-Sci. 9: 513–523.PubMedCrossRefGoogle Scholar
  3. Armstrong, M. D., McMillan, A., and Shaw, K. N. F., 1957, Biochim. Biophys. Acta 25: 422.PubMedCrossRefGoogle Scholar
  4. Assicot, M., and Bohuon, C., 1971, Biochimie 53: 871.PubMedCrossRefGoogle Scholar
  5. Aunis, D., Miras-Portugal, M. T., and Mandel, P., 1973a, Biochim. Biophys. Acta 327: 313.PubMedGoogle Scholar
  6. Aunis, D., Miras-Portugal, M. T., and Mandel, P., 1973b, Biochem. Pharmacol. 22: 2581.CrossRefGoogle Scholar
  7. Aunis, D., Miras-Portugal, M. T., and Mandel, P., 1974, Biochim. Biophys. Acta 365: 259.PubMedGoogle Scholar
  8. Aunis, D., Allard, D., Miras-Portugal, M. T., and Mandel, P., 1975, Biochim. Biophys. Acta, (in press).Google Scholar
  9. Axelrod, J., 1962a, J. Biol. Chem. 237: 1657–1660.PubMedGoogle Scholar
  10. Axelrod, J., 1962b, J. Pharmacol. Exptl. Therap. 138: 28.Google Scholar
  11. Axelrod, J., 1963, Science 140: 499.PubMedCrossRefGoogle Scholar
  12. Axelrod, J., and Tomchick, R. 1958, J. Biol. Chem. 233: 702.PubMedGoogle Scholar
  13. Axelrod, J. and Vessell, E. S., 1970, Mol. Pharmacol. 6: 78.PubMedGoogle Scholar
  14. Axelrod, J., and Weinshilboum, R., 1972, New Engl. J. Med. 287: 237.PubMedCrossRefGoogle Scholar
  15. Axelrod, J., Albers, R. W., and Clemente, C. D., 1959a, J. Neurochem. 5: 68.CrossRefGoogle Scholar
  16. Axelrod, J., Hertting, G., and Patrick, R. W., 1961, J. Pharmacol. Exptl. Therap. 134: 325.Google Scholar
  17. Bagchi, S. P., and McGeer, P. L., 1964, Life Sci. 3: 1195.PubMedCrossRefGoogle Scholar
  18. Barbeau, A., 1961, Proc. 7th Int. Congr. Neurol., vol. 2, p. 925, Societa Grafica Romana, Rome.Google Scholar
  19. Barbeau, A., 1974, Ann. Rev. Pharmacol. 14: 91.CrossRefGoogle Scholar
  20. Bartholini, G., and Pletscher, A., 1968, J. Pharmacol. Exptl. Therap. 161: 14.Google Scholar
  21. Bartholini, G., Haefely, W., Jalfre, M., Keller, H. H., and Pletscher, A. 1972, Brit. J. Pharmacol. 46: 736.Google Scholar
  22. Belleau, B., and Burba, J. 1961, Biochim. Biophys. Acta 54: 195.PubMedCrossRefGoogle Scholar
  23. Bender, D. A., and Coulson, W. F., 1972, J. Neurochem. 19: 2801.PubMedCrossRefGoogle Scholar
  24. Benfey, B. G., Ledoux, G., and Melville, K. I., 1959, Brit. J. Pharmacol. 14: 142.PubMedGoogle Scholar
  25. Bertler, A., 1961, Acta Physiol. Scand. 51: 97–107.CrossRefGoogle Scholar
  26. Bertler, A., and Rosengren, E., 1959a, Acta Physiol. Scand. 47: 350.PubMedGoogle Scholar
  27. Bertler, A., and Rosengren, E., 1959b, Acta Physiol. Scand. 47: 362.PubMedGoogle Scholar
  28. Birkmayer, W., and Hornykiewicz, O., 1961, Wien. Klin. Wochschr. 73: 787.Google Scholar
  29. Bisby, M. A., Fillenz, M., and Smith, A. D., 1973, J. Neurochem. 20: 245.PubMedCrossRefGoogle Scholar
  30. Blaschko, H., 1939, J. Physiol. (Lond.) 96: 50 p.Google Scholar
  31. Blaschko, H., 1952 Pharmacol. Rev. 63: 415.Google Scholar
  32. Blaschko, H., Richter, D., and Schlossmann, H., 1937a, J. Physiol. (Lond.) 90: 1Google Scholar
  33. Blaschko, H., Richter, D., and Schlossmann, H., 1937b, Biochem. J. 31: 2187.PubMedGoogle Scholar
  34. Bloom, F. E., 1972, Catecholamines, in Handbook of Experimental Pharmacology, Vol. 33, H. Blaschko, and E. Muscholl, eds., pp. 46–78, Springer-Verlag, Heidelberg.Google Scholar
  35. Bogdanski, D. F., Weissbach, H., and Udenfriend, S., 1957, J. Neurochem. 1: 272.PubMedCrossRefGoogle Scholar
  36. Bohuon, C., and Assicot, M., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 107–112, Pergamon Press, Oxford.Google Scholar
  37. Brandau, K., and Axelrod, J., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 129–131, Pergamon Press, Oxford.Google Scholar
  38. Brown, G. L., 1960, In: Adrenergic Mechanisms, pp. 116–124, Ciba, Churchill, London. Brown, G. L., 1965, Proc. Roy. Soc. London Ser. B. 162:1.Google Scholar
  39. Brown, G. L., and Gillespie, J. S., 1957, J. Physiol. (London) 138: 81.Google Scholar
  40. Burack, W. R., and Draskoczy, P. R. 1964, J. Pharmacol. Exptl. Therap. 144: 66.Google Scholar
  41. Burn, J. H., and Rand, M. J., 1958, J. Physiol. (London) 144: 314.Google Scholar
  42. Cannon, W. B., and Uridil, J. E., 1921, Am. J. Physiol. 58: 353.Google Scholar
  43. Carlsson, A., 1972, Acta Neurol. Scand. Suppl. 51: 11.PubMedGoogle Scholar
  44. Carlsson, A., Rosengren, E., Bertler, A., and Nilsson, J. 1957, In: Psychotropic Drugs (S. Garattini and V. Ghetti eds.), pp. 363–372, Elsevier, Amsterdam.Google Scholar
  45. Carlsson, A., Lindqvist, M., Magnusson, T., and Waldeck, B., 1958, Science 127: 417.CrossRefGoogle Scholar
  46. Carlsson, A., Falck, B., and Hillarp, N.-A., 1962a, Acta Physiol. Scand. Suppl. 196: 28.Google Scholar
  47. Cattabeni, F., Koslow, S. H., and Costa, E. 1972, Science 178: 166.PubMedCrossRefGoogle Scholar
  48. Celander, O., 1954, Acta Physiol. Scand. Suppl. 116: 128.Google Scholar
  49. Chidsey, C. A., and Harrison, D. C., 1963, J. Pharmacol. Exptl. Therap. 140: 217.Google Scholar
  50. Christenson, J. G., Dairman, W. D., and Udenfriend, S., 1970, Arch. Biochem. Biophys. 141: 356.PubMedCrossRefGoogle Scholar
  51. Chrusciel, T. L., 1960, In: Adrenergic Mechanisms (J. R. Vane, G. E. W. Wolstenholme, and M. O’Connor, eds.), pp. 539, Churchill, London.Google Scholar
  52. Chubb, I. W., Preston, B. N., and Austin, L., 1969, Biochem. J. 111: 243.PubMedGoogle Scholar
  53. Ciaranello, R. D., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 101–105, Pergamon Press, Oxford.Google Scholar
  54. Ciaranello, R. D., Jacobowitz, D., and Axelrod, J. 1973, J. Neurochem. 20: 799.PubMedCrossRefGoogle Scholar
  55. Costa, E., Green, A. R., Koslow, S. H., Lefevre, H. J. Revuelta, A. V., and Wang, C. 1972, Pharmacol. Rev. 24: 167.PubMedGoogle Scholar
  56. Costa, E., and Neff, N. H. 1966, In: Biochemistry and Pharmacology of the Basal Ganglia (E. Costa, L. T. Côte, and M. D. Yahr, eds.), pp. 141–155, Raven Press, New York.Google Scholar
  57. Cotzias, G. C., Papavasiliou, P. S., Ginos, J., Steck, A., and Dliby, S., 1971, Ann. Rev. Med. 22: 305.PubMedCrossRefGoogle Scholar
  58. Coyle, J. T., 1972, Biochem. Pharmacol. 21: 1935.PubMedCrossRefGoogle Scholar
  59. Creveling, C. R., Dalgard, N., Shimizu, H., and Daly, J. W., 1970, Mol. Pharmacol. 6: 691.PubMedGoogle Scholar
  60. Creveling, C. R., Morris, N., Shimizu, H., Ong, H. H., and Daly, J. W., 1972, Mol. Pharmacol. 8: 398.PubMedGoogle Scholar
  61. Crout, J. R., 1964, Proc. Soc. Expt. Biol. Med. 108: 482.Google Scholar
  62. Cuello, A. C., Hiley, R., and Iversen, L. L., 1973, J. Neurochem. 21: 1337.PubMedCrossRefGoogle Scholar
  63. Dahlström, A., 1965, J. Anat. (London) 99: 677.Google Scholar
  64. Dahlström, A., and Fuxe, K., 1965, Acta Physiol. Scand. Suppl. 247: 36.Google Scholar
  65. Dahlström, A., Fuxe, K., and Hillarp, N.-A., 1965, Acta Pharmacol. Toxicol. 22: 277.CrossRefGoogle Scholar
  66. Dairman, W., Christenson, J. G., and Udenfriend, S., 1971, Proc. Natl. Acad. Sci. (U.S.) 68: 2117.CrossRefGoogle Scholar
  67. Dairman, W., Christenson, J. G., and Udenfriend, S., 1972, Pharmacol. Rev. 24: 269.PubMedGoogle Scholar
  68. Dairman, W., Christenson, J. G., and Udenfriend, S., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 61–67, Pergamon Press, Oxford.Google Scholar
  69. Daly, J. W., Axelrod, J., and Witkop, B., 1960, J. Biol. Chem. 235: 1155.PubMedGoogle Scholar
  70. Demis, D. J., Blaschko, H., and Welch, A. D., 1955, J. Pharmacol. Exptl. Therap. 113: 14.Google Scholar
  71. Dengler, H. J., Michaelson, I. A., Spiegel, H. E., and Titus, E. O. 1962, Intern. J. Pharmacol. 1: 23.Google Scholar
  72. Dengler, H. J., Spiegel, H. E., and Titus, E. O. 1961, Science 133: 1072.PubMedCrossRefGoogle Scholar
  73. De Potter, W. P., Smith, D. A., and De Schaepdryver, A. F., 1970, Tissue and Cell 2: 529.PubMedCrossRefGoogle Scholar
  74. De Robertis, E., and Bennett, H. S., 1954, Federation Proc. 13: 35.Google Scholar
  75. De Robertis, E., and Pellegrino De Iraldi, A., 1961a, Experientia 17: 122.CrossRefGoogle Scholar
  76. De Robertis, E., and Pellegrino De Iraldi, A., 1961b, J. Biophys. Biochem. Cytol. 10: 361.CrossRefGoogle Scholar
  77. De Schaepdryver, A. F., and Kirshner, N., 1961, Arch. Intern. Pharmacodyn. Therap. 131: 433.Google Scholar
  78. Diliberto, E. J., Jr., and DiStefano, V., 1969, Anal. Biochem. 32: 281.PubMedCrossRefGoogle Scholar
  79. Douglas, W. W., and Rubin, R. P. 1963, J. Physiol. (London) 167: 288.Google Scholar
  80. Duncan, R. J. S., and Tipton, K. F., 1971, European J. Biochem. 22: 257.CrossRefGoogle Scholar
  81. Eagles, P. A. M., and Iqbal, M., 1974, Brain Res. 80: 177.PubMedCrossRefGoogle Scholar
  82. Eccles, J. C., 1964, The Physiology of Synapses Springer-Verlag, Berlin.Google Scholar
  83. Ehringer, H., and Hornykiewicz, O., 1960, Wien. Klin. Wochschr. 38: 1236.CrossRefGoogle Scholar
  84. Eliasson, R., von Euler, U. S., and Stjärne, L., 1955, Acta Physiol. Scand. Suppl. 118: 69.Google Scholar
  85. Eränko, O., 1952, Acta Anat. (Basel) 16 (Suppl. 16): 60.Google Scholar
  86. Ericsson, A. D., 1971, J. Neurol. Sci., 14: L93.CrossRefGoogle Scholar
  87. Erwin, V. G., and Deitrich, R. A., 1966, J. Biol. Chem. 241: 3533.PubMedGoogle Scholar
  88. Erwin, V. G., Heston, W. D., and Tabakoff, B., 1972, J. Neurochem. 19: 2269.PubMedCrossRefGoogle Scholar
  89. Euler, U. S. von, 1946, Acta Physiol. Scand. 12: 73.CrossRefGoogle Scholar
  90. Euler, U. S. von, 1956, Noradrenaline American Lecture Series (Physiology), (R. F. Pitts, ed.), Charles C. Thomas, Springfield.Google Scholar
  91. Euler, U. S. von, and Lishajko, F., 1963, Acta Physiol. Scand. 57: 468.CrossRefGoogle Scholar
  92. Euler, U. S. von, Franksson, C., and Hellström J., 1954, Acta Physiol. Scand. 31: 1.CrossRefGoogle Scholar
  93. Euler, U. S. von, Björkman, S., and Orwen, I., 1955, Acta Physiol. Scand. Suppl. 118: 10.Google Scholar
  94. Falck, B., 1962, Acta Physiol. Scand. Suppl. 197: 26.Google Scholar
  95. Falck, B., and Hillarp, N.-A., 1959, Acta Anat. 38: 277.PubMedCrossRefGoogle Scholar
  96. Falck, B., and Torp, A., 1961, Med. Exp. 5: 428.PubMedGoogle Scholar
  97. Falck, B., Hillarp, N.-A., Thieme G., and Torp, A., 1962, J. Histochem. Cytochem. 10: 348.CrossRefGoogle Scholar
  98. Foldes, A., and Meek, J. L., 1973, Federation Proc. 32: 797.Google Scholar
  99. Friedhoff, A. J., and Van Winkle, E., 1962, Nature 194: 897.CrossRefGoogle Scholar
  100. Friedhoff, A. J., Schweitzer, J. W., and Miller, J., 1972a, Res. Commun. Pharmacol. Pharm. Pathol. 3: 293.Google Scholar
  101. Friedhoff, A. J., Schweitzer, J. W., and Miller, J., 1972b, Nature 237: 454.PubMedCrossRefGoogle Scholar
  102. Fuller, R. W., and Hunt, J. M., 1967, Life Sci. 6: 1107.PubMedCrossRefGoogle Scholar
  103. Fuller, R. W., Warren, B. J., and Molloy, B. B. 1970, Biochim. Biophys. Acta 222: 210.PubMedCrossRefGoogle Scholar
  104. Fuxe, K. 1966, Pharmacol. Rev. 18: 641.Google Scholar
  105. Fuxe, K., and Ungerstedt, U., 1970, Symposium on Amphetamine and Related Compounds (E. Costa and S. Garattini, eds.), pp. 257–288, Raven Press, New York.Google Scholar
  106. Fuxe, K., Goldstein, M., Hökfelt, T., Freedman, L., and Anagnoste, B., 1971, Acta Pharmacol. Toxicol. 29 (Suppl. 4): 15.Google Scholar
  107. Fuxe, K., Goldstein, M., Hökfelt, T., Joh, T. H., Freedman, L. S., and Anagnoste, B., 1972, Federation Proc. 31: 544.Google Scholar
  108. Gabay, S., and Valcourt, A. J., 1968, Biochim. Biophys. Acta 159: 440.PubMedGoogle Scholar
  109. Gaddum, J. H., and Kwiatkowski, H., 1939, J. Physiol. (London) 96: 385.Google Scholar
  110. Geffen, L., 1974, Life Sci. 14: 1593.PubMedCrossRefGoogle Scholar
  111. Geffen, L. B., and Ostberg, A., 1969, J. Physiol. (London) 204: 583.Google Scholar
  112. Geffen, L. B., and Rush, R. A. 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 483–489, Pergamon Press, Oxford.Google Scholar
  113. Gillespie, J. S., and Kirpekar, S. M., 1965, J. Physiol. (London) 178: 44 p.Google Scholar
  114. Glowinski, J., and Axelrod, J., 1966, Pharmacol. Rev. 18: 775.PubMedGoogle Scholar
  115. Glowinski, J., and Iversen, L. L. 1966, J. Neurochem. 13: 655.PubMedCrossRefGoogle Scholar
  116. Glowinski, J., Kopin, I. J., and Axelrod, J.. 1965, J. Neurochem. 12: 25.PubMedCrossRefGoogle Scholar
  117. Goldstein, M., 1966, Pharmacol. Rev. 18: 77.PubMedGoogle Scholar
  118. Goldstein, M., 1972, In: Research Methods in Neurochemistry (N. Marks and R. Rodnight, eds.), pp. 317–340, Plenum Press, New York.Google Scholar
  119. Goldstein, M., and Gerber, H., 1963, Life Sci. 2: 97.PubMedCrossRefGoogle Scholar
  120. Goldstein, M., Anagnoste, B., Yamamoto, H., and Fetch, W. C., 1970, J. Pharmacol. Exptl. Therap. 171: 196.Google Scholar
  121. Goldstein, M., Ohi, Y., and Backstrom, T., 1970a, J. Pharmacol. Exptl. Therap. 174: 77.Google Scholar
  122. Goldstein, M., Freedman, L. S., and Backstrom, T., 1970b, J. Pharm. Pharmacol. 22: 715.PubMedCrossRefGoogle Scholar
  123. Goldstein, M., Anagnoste, B., Freedman, L. S., Roffman, M., Ebstein, R. P., Park, D. H., Fuxe, K., and Hökfelt, T., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 69–78, Pergamon Press, Oxford.Google Scholar
  124. Goldstein, M., and Weiss, Z. 1965, Life Sci. 4: 261.PubMedCrossRefGoogle Scholar
  125. Gray, E. G., and Whittaker, V. P., 1962, J. Anat. 96: 79.PubMedGoogle Scholar
  126. Haefely, W., Hiirlimann, A., and Thoenen, H., 1965, J. Physiol. (London) 181: 48.Google Scholar
  127. Hagen, P., 1956, J. Pharmacol. Exptl. Therap. 116: 26.Google Scholar
  128. Hall, D. W. R., Logan, B. W., and Parsons, G. H., 1969, Biochem. Pharmacol. 18: 1447PubMedCrossRefGoogle Scholar
  129. Hamberger, B., Malmfors, T., Norberg, K. A., and Sachs, C., 1964, Biochem. Pharmacol. 13: 841.PubMedCrossRefGoogle Scholar
  130. Hare, M. L. C., 1928, Biochem. J. 22: 968.PubMedGoogle Scholar
  131. Harris, J. E., and Roth, R. H., 1971, Mol. Pharmacol. 7: 593.PubMedGoogle Scholar
  132. Hertting, G., 1964, Biochem. Pharmacol. 13: 1119.PubMedCrossRefGoogle Scholar
  133. Hertting, G., and Axelrod, J., 1961, Nature 192: 172.PubMedCrossRefGoogle Scholar
  134. Hertting, G., Axelrod, J., Kopin, I. J., and Whitby, L. G., 1961, Nature 189: 66.PubMedCrossRefGoogle Scholar
  135. Herrting, G., Potter, L. T., and Axelrod, J. 1962, J. Pharmacol. Exptl. Therap. 136: 289.Google Scholar
  136. Hess, S. M., Connamacher, R. H., Ozaki, M., and Udenfriend, S., 1961, J. Pharmacol. Exptl. Therap. 134: 129.Google Scholar
  137. Idaka, H., 1973, In: Frontiers in Catecholamine Research, (E. Usdin and S. Snyder, eds.,), pp. 87–90, Pergamon Press, Oxford.Google Scholar
  138. Hillarp, N.-A., and Hökfelt, T., 1953, Acta Physiol. Scand. 30: 55.PubMedCrossRefGoogle Scholar
  139. Himwich, H. E., and Alpers, H. S., 1970, Ann. Rev. Pharmacol. 10: 213.CrossRefGoogle Scholar
  140. Hökfelt, T., 1968, Z. Zellforsch. 91: 1.PubMedCrossRefGoogle Scholar
  141. Hökfelt, T., 1969, Acta Physiol. Scand. 76: 427.PubMedCrossRefGoogle Scholar
  142. Hökfelt, T., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 439–446, Pergamon Press, Oxford.Google Scholar
  143. Holtz, P., 1950, Acta Physiol. Scand. 20: 354.PubMedCrossRefGoogle Scholar
  144. Holtz, P., Heise, R., and Ludtke, K., 1938, Arch. Exptl. Pathol. Pharmakol. 191: 87.CrossRefGoogle Scholar
  145. Holzbauer, M. and Vogt, M., 1956, J. Neurochem. 1: 8.PubMedCrossRefGoogle Scholar
  146. Houslay, M. D., and Tipton, K. E., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 147–149, Pergamon Press, Oxford.Google Scholar
  147. Ikeda, M., Fahien, L. A., and Udenfriend, S., 1966, J. Biol. Chem. 241: 4452.PubMedGoogle Scholar
  148. Ikeda, M., Levitt, M., and Udenfriend, S., 1965, Biochem. Biophys. Res. Commun. 18: 482.PubMedCrossRefGoogle Scholar
  149. Iversen, L. L., 1963, Brit. J. Pharmacol. Chemother. 21: 523.Google Scholar
  150. Iversen, L. L., 1965, Brit. J. Pharmacol. Chemother. 25: 18.Google Scholar
  151. Iversen, L. L., and Glowinski, J., 1966, J. Neurochem. 13: 671.PubMedCrossRefGoogle Scholar
  152. Iversen, L. L., Glowinski, J., and Axelrod, J., 1966, J. Pharmacol. Exptl. Therap. 151: 273.Google Scholar
  153. Iversen, L. L., and Whitby, L. G., 1962, Brit. J. Pharmacol. Chemother. 19: 355.Google Scholar
  154. Joh, T. H., and Goldstein, M., 1973, Mol. Pharmacol. 9: 117.PubMedGoogle Scholar
  155. Johnston, J. P., 1968, Biochem. Pharmacol. 17: 1285.PubMedCrossRefGoogle Scholar
  156. Joyce, D., 1962, Brit. J. Pharmacol. 18: 370.PubMedGoogle Scholar
  157. Kapeller, K., and Major, D., 1967, Proc. Roy. Soc. London Ser B 167: 282.CrossRefGoogle Scholar
  158. Katz, R. I., Goodwin, J. S., and Kopin, I. J., 1969, Life Sci. (Part 11)8:561.Google Scholar
  159. Katz, R. I., and Jacobson, A. E., 1972, Mol. Pharmacol. 8: 594.PubMedGoogle Scholar
  160. Kaufman, S. 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 53–60, Pergamon Press, Oxford.Google Scholar
  161. Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T., and Attack, C. (1972) J. Pharm. Pharmacol. 24: 744.PubMedCrossRefGoogle Scholar
  162. Kirshner, N., and Goodall, McC. 1956, Federation Proc. 15: 110.Google Scholar
  163. Kirshner, N., and Goodall, McC., 1957, Biochim. Biophys. Acta 24: 658.PubMedCrossRefGoogle Scholar
  164. Kitabchi, A. E., and Williams, R. H., 1969, Biochim. Biophys. Acta 178: 181.PubMedGoogle Scholar
  165. Koelle, G. B., 1959, Pharmacol. Rev. 11: 381.PubMedGoogle Scholar
  166. Kopin, I.J., 1964, Pharmacol. Rev. 16: 179.PubMedGoogle Scholar
  167. Kopin, I. J., 1968, Ann. Rev. Pharmacol. 8: 377.PubMedCrossRefGoogle Scholar
  168. Kopin, I. J., and Gordon, E. K., 1962, J. Pharmacol. Exptl. Therap. 138: 351.Google Scholar
  169. Kopin, I. J., and Gordon, E. K., 1963a, J. Pharmacol. Exptl. Therap. 140: 207.Google Scholar
  170. Kopin, I. J., Gordon, E. K., and Horst, W. D. 1965, Biochem. Pharmacol. 14: 753.PubMedCrossRefGoogle Scholar
  171. Kopin, I. J., Weise, V. K., and Sedvall, G. C. 1969, J. Pharmacol. Exptl. Therap. 170: 246.Google Scholar
  172. Koslow, S. H., Cattabeni, F., and Costa, E., 1972, Science 176: 177.PubMedCrossRefGoogle Scholar
  173. Krakoff, L. R., and Axelrod, J., 1967, Biochem. Pharmacol. 16: 1384.PubMedCrossRefGoogle Scholar
  174. Kuczenski, R. T., and Mandell, A. J., 1972, J. Biol. Chem. 247: 3114.PubMedGoogle Scholar
  175. Kuehl, F. A., Jr., Ormond, R. E., and Vandenheuvel, W. J. A., 1966, Nature 211: 606.PubMedCrossRefGoogle Scholar
  176. Kukovetz, W. R., Hess, M. E., Shanfield, J., and Haugaard, N., 1959, J. Pharmacol. Exptl. Therap. 127: 122.Google Scholar
  177. Laduron, P., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 121–128, Pergamon Press, Oxford.Google Scholar
  178. Lancaster, G. A., and Sourkes, T. L., 1972, Can. J. Biochem. 50: 791.PubMedCrossRefGoogle Scholar
  179. Lapetina, E. G., Soto, E. F., and De Robertis, E., 1968, J. Neurochem. 15: 437.PubMedCrossRefGoogle Scholar
  180. Laverty, R., Michaelson, I. A., Sharman, D. F., and Whittaker, V. P., 1963, Brit. J. Pharmacol. Chemother. 21: 482.Google Scholar
  181. Leeper, L. C., and Udenfriend, S., 1956, Federation Proc. 15: 298.Google Scholar
  182. Lever, J. D., and Esterhuizen, A. C., 1961, Nature 192: 566.PubMedCrossRefGoogle Scholar
  183. Levin, E. Y., and Kaufman, S., 1961, J. Biol. Chem. 236: 2043.PubMedGoogle Scholar
  184. Lindvall, O., Björklund, A., and Falck, B., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 683–687, Pergamon Press, Oxford.Google Scholar
  185. Loewi, O. 1921, Pf iiiegers Arch. Ges. Physiol. 189: 239.CrossRefGoogle Scholar
  186. Lovenberg, W., Weissbach, H., and Udenfriend, S., 1962, J. Biol. Chem. 237: 89.PubMedGoogle Scholar
  187. Mandel, P., Ciesielski-Treska, J., Hermetet, J. C., Hertz, L., Nissen, C., Tholey, G. and Warter, F., 1974, In: Central Nervous System. Studies on Metabolic Regulation and Function (E. Genazzani and H. Herken, eds.), pp. 223–230, Springer-Verlag, Berlin.Google Scholar
  188. Marks, B. H., Samorajski, T., and Webster, E. J., 1962, J. Pharmacol. Exptl. Therap. 138: 376.Google Scholar
  189. Masri, M. S., Booth, A. N., and Deeds, F., 1962, Biochim. Biophys. Acta 65: 495.CrossRefGoogle Scholar
  190. Masri, M. S., Robbins, D. J., Emerson, O. H., and Deeds, F., 1964, Nature 202: 878.PubMedCrossRefGoogle Scholar
  191. Masuoka, D. T., Clark, W. G., and Schott, H. F., 1961, Rev. Canad. Biol. 20: 1.Google Scholar
  192. Masuoka, D. T., Schott, H. F., Akawie, R. I., and Clark, W. G., 1956, Proc. Soc. Exptl. Biol. Med. 93: 5.Google Scholar
  193. Masuoka, D. T., Schott, H. F., and Petriello, L., 1963, J. Pharmacol. Exptl. Therap. 139: 73.Google Scholar
  194. Mathieu, P., and Revol, L., 1970, Bull. Soc. Chim. Biol. 52: 1039.PubMedGoogle Scholar
  195. McGeer, E. G., and McGeer, P. L. 1962, Can. J. Biochem. Physiol. 40: 1141.CrossRefGoogle Scholar
  196. Meek, J. L., and Foldes, A., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 167–171, Pergamon Press, Oxford.Google Scholar
  197. Meek, J. L., and Neff, N. H., 1973, J. Neurochem. 21: 1.PubMedCrossRefGoogle Scholar
  198. Mena, I., Crout, J., and Cotzias, G. C., 1971, J. Am. Med. Assoc. 218: 1829–1830.CrossRefGoogle Scholar
  199. Miras-Portugal, M. T., Aunis, D., and Mandel, P. 1975a, Biochimie (in press).Google Scholar
  200. Mirkin, B. L., and Bonnycastle, D. D., 1954, Am. J. Physiol. 178: 529.PubMedGoogle Scholar
  201. Molinoff, P. B., and Axelrod, J., 1971, Ann. Rev. Biochem. 40: 465.PubMedCrossRefGoogle Scholar
  202. Montagu, K. A. 1957, Nature 180: 244.PubMedCrossRefGoogle Scholar
  203. Montagu, K. A., 1963, Biochem. J. 86: 9.PubMedGoogle Scholar
  204. Moore, R. Y. 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 767–769, Pergamon Press, Oxford.Google Scholar
  205. Mueller, R. A., Thoenen, H., and Axelrod, J., 1969a, J. Pharmacol. Exptl. Therap. 169: 74.Google Scholar
  206. Mueller, R. A., Thoenen, H., and Axelrod, J., 1969b, Mol. Pharmacol. 5: 463.PubMedGoogle Scholar
  207. Musacchio, J. M., d’Angelo, G. L., and McQueen, C. A., 1971a, Proc. Natl. Acad. Sci. (U.S.) 68: 2087.CrossRefGoogle Scholar
  208. Musacchio, J. M., and Craviso, G. L., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 47–52, Pergamon Press, Oxford.Google Scholar
  209. Musacchio, J. M., McQueen, C. A., and Craviso, G. L., 1973, In: New Concepts in Neurotransmitter Regulation (A. J. Mandell, ed.), pp. 69–88, Plenum Press, New York.Google Scholar
  210. Nagatsu, T., Kato, T., Kuzuya, H., Umezawa, H. and Takenchi, T. 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 83–86, Pergamon Press, Oxford.Google Scholar
  211. Nagatsu, T., Levitt, M., and Udenfriend, S., 1964, Biochem. Biophys. Res. Commun. 14: 543.PubMedCrossRefGoogle Scholar
  212. Nagatsu, T., Mizutani, K., Nagatsu, I., Matsuura, S., and Sugimoto, T. 1972, Biochem. Pharmacol. 21: 1945.PubMedCrossRefGoogle Scholar
  213. Nakashima, Y., Suzue, R., Sanada, H., and Kowada, S., 1972, Arch. Biochem. Biophys. 152: 515.PubMedCrossRefGoogle Scholar
  214. Neff, N. H., Yang, H. Y. T., and Goridis, C. (1973) In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 133–138, Pergamon Press, Oxford.Google Scholar
  215. Neri, R., Hayano, M., Stone, D., Dorfman, R. I., and Elmanjian, F., 1956, Arch. Biochem. Biophys. 60: 297.PubMedCrossRefGoogle Scholar
  216. Nickerson, M., Berghout, J., and Hammerström, R. N., 1950, Am. J. Physiol. 160: 479.PubMedGoogle Scholar
  217. Nikodijevik B., Daly, J., and Creveling, C. R., 1969, Biochem. Pharmacol. 18: 1577.CrossRefGoogle Scholar
  218. Nobin, A., and Björklund, A., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 677–681, Pergamon Press, Oxford.Google Scholar
  219. Palade, G. E., and Palay, S. L. 1954, Anat. Rec. 188, 335.Google Scholar
  220. Pellerin, J., and d’Iorio, A., 1957, Can. J. Biochem. Physiol. 35: 151.PubMedCrossRefGoogle Scholar
  221. Perry, T. L., Hansen, S., and Macintyre, L., 1964, Nature 202: 519.PubMedCrossRefGoogle Scholar
  222. Petrak, B., Fetzer, V., and Altiere, R. 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 97–100, Pergamon Press, Oxford.Google Scholar
  223. Pletscher, A., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 27–37, Pergamon Press, Oxford.Google Scholar
  224. Pletscher, A., Brossi, A., and Gey, K. F., 1962, Intern. Rev. Neurobiol. 4: 275.CrossRefGoogle Scholar
  225. Pletscher, A., Gey, K. F., and Burkard, W. P., 1966, In: Handbook of Experimental Pharmacology Vol. 19, (O. Eichler and A. Farah, eds.), pp. 593–735, Springer-Verlag, Berlin.Google Scholar
  226. Pohorecky, L. A., Zigmond, M., Karten, H., and Wurtman, R. J., 1969, J. Pharmacol. Exptl. Therap. 165: 190.Google Scholar
  227. Porter, C. C., 1971, Federation Proc. 30: 871.Google Scholar
  228. Potter, T. L., and Axelrod, J., 1963, J. Pharmacol. Exptl. Therap. 142: 291.Google Scholar
  229. Raab, W., and Gigee, W., 1953, Arch. Exptl. Pathol. Pharmak. 219: 248.Google Scholar
  230. Raab, W., and Gigee, W., 1955, Circulation Res. 3: 553.PubMedGoogle Scholar
  231. Raab, W., and Humphreys, R. J., 1947, J. Pharmacol. Exptl. Therap. 89: 64.Google Scholar
  232. Raskin, N. H., and Sokoloff, L., 1970, J. Neurochem. 17: 1677.PubMedCrossRefGoogle Scholar
  233. Rose11, S., Kopin, I. J., and Axelrod, J., 1963, Am. J. Physiol. 205: 317.PubMedGoogle Scholar
  234. Ross, S. B., and Haljasmaa, O., 1964, Acta Pharmacol. Toxicol. Scand. 21: 215.CrossRefGoogle Scholar
  235. Ross, S. B., and Renyi, A. L., 1964, Acta Pharmacol. Toxicol. Scand. 21: 226.CrossRefGoogle Scholar
  236. Rutledge, C. O., and Jonason, J., 1967, J. Pharmacol. Exptl. Therap. 157: 493.Google Scholar
  237. Saelens, J. K., Schoen, M. S., and Kovacsics, G. B., 1967, Biochem. Pharmacol. 16: 1043.PubMedCrossRefGoogle Scholar
  238. Samorajski, T., and Marks, B. H. 1962, J. Histochem. Cytochem. 10: 392.CrossRefGoogle Scholar
  239. Sano, I., Gamo T., Kakimoto, Y., Taniguchi, K., Takesada, M., and Nishinuma, K., 1959, Biochim. Biophys. Acta 32: 586.PubMedCrossRefGoogle Scholar
  240. Schanberg, S. M., Breese, G. R., Schildkraut, J. J., Gordon, E. K., and Kopin, I., 1968, Biochem. Pharmacol. 17: 2006.PubMedCrossRefGoogle Scholar
  241. Schayer, R. W., 1951, J. Biol. Chem. 189: 301.PubMedGoogle Scholar
  242. Seiler, N., and Wiechmann, M. 1967, J. Chromatog. 28: 351.CrossRefGoogle Scholar
  243. Sen, N. P., and McGeer, P. L., 1964, Biochem. Biophys. Res. Commun. 14: 227.PubMedCrossRefGoogle Scholar
  244. Senoh, S., Daly, J., Axelrod, J., and Witkop, B., 1959, J. Am. Chem. Soc. 81: 6240.CrossRefGoogle Scholar
  245. Shiman, R., Akino, M., and Kaufman, S. 1971, J. Biol. Chem. 246: 1330.PubMedGoogle Scholar
  246. Shiman, R., and Kaufman, S., 1970, Methods in Enzymology Vol. 17A, pp. 609–615.CrossRefGoogle Scholar
  247. Shimizu, H., and Daly, J. W., 1972, European J. Pharmacol. 17: 240.CrossRefGoogle Scholar
  248. Shore, P. A., 1972, Ann. Rev. Pharmacol. 12: 209.PubMedCrossRefGoogle Scholar
  249. Silberstein, S. D., Shein, H. M., and Ber, K. R., 1972, Brain Res. 41: 245.PubMedCrossRefGoogle Scholar
  250. Sims, K. L., and Bloom, F. E., 1973, Brain Res. 49: 165.PubMedCrossRefGoogle Scholar
  251. Sims, K. L., Davis, G. A., and Bloom, F. E., 1973, J. Neurochem. 20: 449.PubMedCrossRefGoogle Scholar
  252. Sjoerdsma, A., 1961, Circulation Res. 9: 734.Google Scholar
  253. Sjoerdsma, A., 1966, Pharmacol. Rev. 18: 673.PubMedGoogle Scholar
  254. Sjöstrand, F. S., 1954, Z. Wiss. Mikroskopie. 62: 65.Google Scholar
  255. Smith, A. D., 1968, In: A Symposium on the Interaction of Drugs and Subcellular Components in Animal Cells (P. N. Campbell, ed.), pp. 239–292, J. & A. Churchill, London.Google Scholar
  256. Smith, D. S., Järlfors, U., and Beraneck, R., 1970, J. Cell Biol. 46: 199.PubMedCrossRefGoogle Scholar
  257. Sourkes, T. L., 1954, Arch. Biochem. Biophys. 51: 444.PubMedCrossRefGoogle Scholar
  258. Spector, S., Gordon, R., Sjoerdsma, A., and Udenfriend, S., 1967, Mol. Pharmacol. 3: 549.PubMedGoogle Scholar
  259. Spector, S., Sjoerdsma, A., and Udenfriend, S., 1965, J. Pharmacol. Exptl. Therap. 147: 86.Google Scholar
  260. Squires, R. F. 1972, In: Advances in Biochemical Psychopharmacology Vol. 5, (E. Costa, ed.), pp. 355–370, Raven Press, New York.Google Scholar
  261. Stabenan, J. R., Creveling, C. R., and Daly, J., 1970, Am. J. Psychiat. 127: 611.Google Scholar
  262. Stinson, R. H., 1961, Can. J. Biochem. Physiol. 39: 309.CrossRefGoogle Scholar
  263. Sugden, R. F., and Eccleston, D. J., 1971, J. Neurochem. 18: 2461.PubMedCrossRefGoogle Scholar
  264. Sulser, F., and Sanders-Bush, E., 1971, Ann. Rev. Pharmacol. 11: 209.PubMedCrossRefGoogle Scholar
  265. Tabakoff, B., and Erwin, V. G., 1970, J. Biol. Chem. 245: 3263.PubMedGoogle Scholar
  266. Taylor, K. M., and Laverty, R., 1969, J. Neurochem. 16: 1367.PubMedCrossRefGoogle Scholar
  267. Thoenen, H., Kettler, R., Burkard, W., and Saner, A., 1971, NaunynSchmiedebergs Arch. Exptl. Pathol. Pharmak. 270: 146.Google Scholar
  268. Thomas, J. A., Van Orden, L. S., III, Redick, J. A., and Kopin, I. J., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 79–81, Pergamon Press, Oxford.Google Scholar
  269. Thureson-Klein, A., Klein, R. L., Lagercrantz, H., and Stjärne, L., 1970, Experientia 26: 994PubMedCrossRefGoogle Scholar
  270. Tranzer, J. P., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 453–458, Pergamon Press, Oxford.Google Scholar
  271. Tranzer, J. P., and Thoenen, H., 1967, Experientia 23: 123.CrossRefGoogle Scholar
  272. Tranzer, J. P., and Thoenen, H., 1968, Experientia 24: 484.PubMedCrossRefGoogle Scholar
  273. Turner, A. J., and Tipton, K. F. 1972, European J. Biochem. 30: 361.CrossRefGoogle Scholar
  274. Udenfriend, S., 1962Fluorescence Assay in Biology and Medicine Academic Press, New York.Google Scholar
  275. Udenfriend, S., and Wyngaarden, J. B., 1956, Biochim. Biophys. Acta 20: 48.PubMedCrossRefGoogle Scholar
  276. Udenfriend, S., and Zaltzman-Nirenberg, P., 1963, Science 142: 394.PubMedCrossRefGoogle Scholar
  277. Udenfriend, S., Creveling, C. R., Ozaki, M., Daly, J. W., and Witkop, B., 1959, Arch. Biochem. Biophys. 84: 249.PubMedCrossRefGoogle Scholar
  278. Udenfriend, S., Zaltzman-Nirenberg, P., and Nagatsu, T., 1965, Biochem. Pharmacol. 14: 837.PubMedCrossRefGoogle Scholar
  279. Ungerstedt, U., 1968, European J. Pharmacol. 5: 107.CrossRefGoogle Scholar
  280. Ungerstedt, U., and Ljungberg, T., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 689–693, Pergamon Press, Oxford.Google Scholar
  281. Viveros, O. H., Arqueros, L., and Kirshner, N., 1968, Life Sci. 7: 609.CrossRefGoogle Scholar
  282. Wagner, A. F., Cirillo, V. J., Meisinger, M. A. P., Ormond, R. E., Kuehl, F., Jr., and Brink, N. G., 1966, Nature 211: 604.PubMedCrossRefGoogle Scholar
  283. Weil-Malherbe, H., 1961, In: Methods in Medical Research Vol. IX (Quastel, ed.), pp. 130–146.Google Scholar
  284. Weil-Malherbe, H., and Bone, A. D., 1952, Biochem. J. 51: 311.PubMedGoogle Scholar
  285. Weiner, N. 1970, Ann. Rev. Pharmacol. 10: 273.PubMedCrossRefGoogle Scholar
  286. Weiner, N., and Selvaratnam, I., 1968, J. Pharmacol. Exptl. Therap. 161: 21.Google Scholar
  287. Whitby, L. G., Axelrod, J., and Weil-Malherbe, H., 1961, J. Pharmacol. Exptl. Therap. 132: 193.Google Scholar
  288. Whitsett, T. L., McKinney, A. S., and Goldberg, L. I., 1970, Clin. Res. 18: 28.Google Scholar
  289. Whittaker, V. P., 1966, Ann. N.Y. Acad. Sci. 137: 982.PubMedCrossRefGoogle Scholar
  290. Wolfe, D. E., Potter, L. T., Richardson, K. C., and Axelrod, J., 1962 Science 138: 440.PubMedCrossRefGoogle Scholar
  291. Woods, R. I., 1970, Proc. Roy. Soc. London Ser B 176: 63.CrossRefGoogle Scholar
  292. Yahr, M. D., Duvoisin, R. C., Shear, M. J., Barrett, R. E., and Hoeln, M. M., 1969, Arch. Neurol. 21: 343.PubMedCrossRefGoogle Scholar
  293. Youdim, M. B. H., 1972 Monoamine oxidases: New vistas in: Advances in Biochemical Psychopharmacology, Vol. 5(E. Costa and M. Sandler, eds.), pp. 67–77,Raven Press, New York.Google Scholar
  294. Zeller, E. A., and Barsky, J., 1952, Proc. Soc. Exptl. Biol. 81: 459.Google Scholar
  295. Zeller, E. A., and Hsu, M., 1973, In: Frontiers in Catecholamine Research, (E. Usdin and S. Snyder, eds.), pp. 153–155, Pergamon Press, Oxford.Google Scholar
  296. Zeller, E. A., Barsky, J., Berman, E. R., and Fouts, J. R., 1952, J. Lab. Clin. Med. 40: 965.Google Scholar

Copyright information

© Plenum Press, New York 1975

Authors and Affiliations

  • Paul Mandel
    • 1
  • Gérard Mack
    • 1
  • Christo Goridis
    • 1
  1. 1.Centre de Neurochimie du CNRSInstitut de Chimie Biologique Faculté de MédecineStrasbourgFrance

Personalised recommendations